AUROBINDO PHARMA LTD. - 524804 - Unit III Of Eugia Pharma Specialities Ltd., Receives Warning Letter From US FDA

Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Slowing Down Stock

1036.0000 1.10 (0.11%)

NSE Sep 04, 2025 15:31 PM

Near 52W Low of ₹1010.00

Volume: 422.5K

Aurobindo Pharma Ltd.

16 Aug 2024

1036.00

0.11%

Company Update

AUROBINDO PHARMA LTD. - 524804 - Unit III Of Eugia Pharma Specialities Ltd., Receives Warning Letter …

BSE India

Intimation of receipt of Warning Letter from US FDA for Unit III of Eugia Pharma Specialities Limited, a wholly owned subsidiarity of the Company

More from Aurobindo Pharma Ltd.

Recommended

Retail investor wave powers mutual funds to record momentum

The Baseline | 04 Sep 2025, 04:05PM

Market trades higher, MosChip Technologies surges as PM Modi announces that work is underway for ISM 2.0

Trendlyne Marketwatch | 04 Sep 2025, 03:28PM

A deal is called off, increasing the chance for Aurobindo Pharma to be debt free